171 related articles for article (PubMed ID: 18061522)
21. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
22. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
[TBL] [Abstract][Full Text] [Related]
23. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.
Drake RR; Cazare LH; Semmes OJ; Wadsworth JT
Expert Rev Mol Diagn; 2005 Jan; 5(1):93-100. PubMed ID: 15723595
[TBL] [Abstract][Full Text] [Related]
24. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
Liu CJ; Lin SC; Yang CC; Cheng HW; Chang KW
Head Neck; 2012 Feb; 34(2):219-24. PubMed ID: 22083872
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma.
Kim DH; Gong EJ; Jung HY; Lim H; Ahn JY; Choi KS; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH; Roh JL; Choi SH; Nam SY; Kim SY; Baek S
Scand J Gastroenterol; 2014 Dec; 49(12):1486-92. PubMed ID: 25372595
[TBL] [Abstract][Full Text] [Related]
26. Potential Salivary Proteomic Markers of Oral Squamous Cell Carcinoma.
Gallo C; Ciavarella D; Santarelli A; Ranieri E; Colella G; Lo Muzio L; Lo Russo L
Cancer Genomics Proteomics; 2016; 13(1):55-61. PubMed ID: 26708599
[TBL] [Abstract][Full Text] [Related]
27. Risk Stratification System for Oral Cancer Screening.
Pereira LH; Reis IM; Reategui EP; Gordon C; Saint-Victor S; Duncan R; Gomez C; Bayers S; Fisher P; Perez A; Goodwin WJ; Hu JJ; Franzmann EJ
Cancer Prev Res (Phila); 2016 Jun; 9(6):445-55. PubMed ID: 27020654
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
29. Evolving role of human papillomavirus as a clinically significant biomarker in head and neck squamous cell carcinoma.
McMullen C; Chung CH; Hernandez-Prera JC
Expert Rev Mol Diagn; 2019 Jan; 19(1):63-70. PubMed ID: 30575409
[No Abstract] [Full Text] [Related]
30. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma.
Chuang AY; Chuang TC; Chang S; Zhou S; Begum S; Westra WH; Ha PK; Koch WM; Califano JA
Oral Oncol; 2008 Oct; 44(10):915-9. PubMed ID: 18329326
[TBL] [Abstract][Full Text] [Related]
31. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
32. Salivaomics in oral cancer.
Aro K; Kaczor-Urbanowicz K; Carreras-Presas CM
Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):91-97. PubMed ID: 30507690
[TBL] [Abstract][Full Text] [Related]
33. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
[TBL] [Abstract][Full Text] [Related]
34. Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
van Ginkel JH; Slieker FJB; de Bree R; van Es RJJ; Van Cann EM; Willems SM
Oral Oncol; 2017 Dec; 75():8-15. PubMed ID: 29224828
[TBL] [Abstract][Full Text] [Related]
35. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
Guruaribam VD; Sarumathi T
J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
[TBL] [Abstract][Full Text] [Related]
36. Salivary biomarkers as tools for oral squamous cell carcinoma diagnosis: A systematic review.
Stuani VT; Rubira CM; Sant'Ana AC; Santos PS
Head Neck; 2017 Apr; 39(4):797-811. PubMed ID: 27898189
[TBL] [Abstract][Full Text] [Related]
37. [Study of aberrant methylation of TSG in saliva in case of upper-aerodigestive-tract cancer].
Righini CA; de Fraipont F; Timsit JF; Dassonville O; Milano G; Moro-Sibilot D
Rev Stomatol Chir Maxillofac; 2008 Sep; 109(4):226-32. PubMed ID: 18760810
[TBL] [Abstract][Full Text] [Related]
38. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
[TBL] [Abstract][Full Text] [Related]
39. Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer.
Hamakawa H; Fukizumi M; Bao Y; Sumida T; Onishi A; Tanioka H; Sato H; Yumoto E
Clin Exp Metastasis; 1999; 17(7):593-9. PubMed ID: 10845558
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers in saliva for the detection of oral squamous cell carcinoma and their potential use for early diagnosis: a systematic review.
Gualtero DF; Suarez Castillo A
Acta Odontol Scand; 2016; 74(3):170-7. PubMed ID: 26577643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
